Document is current
Any future updates will be listed below
-
Authors
Nassuuna, Jacent
Sterk, Joas
Walusimbi, Bridgious
Natukunda, Agnes
Nkangi, Ronald
Amongin, Rebecca
Zirimenya, Ludoviko
Webb, Emily L.
Elliott, Alison M.
Nkurunungi, Gyaviira
-
Funding
Funding for this research was provided by:
DELTAS Africa Initiative (DEL-15-004, DEL-15-004)
Royal Society (R120442, R120442)
National Institute for Health and Care Research (NIHR134531, NIHR134531, NIHR134531, NIHR134531)
Medical Research Council (MR/R010161/1, MR/R02118X/1)
European and Developing Countries Clinical Trials Partnership (TMA2019PF-2707)
Wellcome Trust (224263/Z/21/Z)
- License Information
-
More Information
Article History
Received: 4 October 2024
Accepted: 17 March 2025
First Online: 26 March 2025
Competing interests
: G.N. and A.M.E. report grants from Wellcome Trust. G.N. reports funding from the EDCTP2 programme supported by the European Union. A.M.E. reports funding from Medical Research Council (MRC) of the United Kingdom for conduct of the parent study; A.M.E. reports funding from NIH, Science for Africa Foundation, the Royal Society, and DELTAS Africa, outside the submitted work. A.M.E. and A.N. report support from UK National Institute of Health and care Research (NIHR). A.M.E. further reports support from the Serum Institute of India, Uganda National Expanded Programme on Immunisation, and Emergent BioSolutions for conduct of the parent study. All other authors declare no competing interests.
